• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today

Clinical Data

The latest clinical trial data, study results, and research findings shaping drug development decisions across the pharmaceutical industry.

valentines day fail
Pharma

Unapproved in US for decades, levosimendan stumbles in ph. 3

Despite the flop, Tenax has zeroed in on a prespecified subgroup of patients with greater disease burden and plans to request a meeting with the FDA.
Angus Liu Aug 10, 2026 4:40pm
Doctor diagnoses kidney

In a first, Otsuka’s Voyxact stabilizes IgAN kidney loss in ph.3

Aug 3, 2026 5:00pm
Karyopharm

Karyopharm reports Xpovio miss, FDA filing in separate cancers

Jul 31, 2026 10:00am
photo of a pair of hands that show the skin condition vitiligo

Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie

Jul 30, 2026 2:15pm
Boerner

BMS delays key Cobenfy, milvexian readouts amid Q2 beat

Jul 30, 2026 10:12am
monumental

J&J bispecific combo delivers 89% PFS benefit in myeloma

Jul 23, 2026 8:30am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings